Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
a Potential
.
Show all posts
Showing posts with label
a Potential
.
Show all posts
Wednesday, August 21, 2024
Ipsen’s Onivyde Regimen, a Potential New Standard-of-Care First-Line Therapy in Metastatic Pancreatic Adenocarcinoma, Approved by FDA
›
Ipsen (Euronext: IPN; ADR: IPSEY) announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug ap...
›
Home
View web version
